Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The neuropeptide Y receptor subtype 2 (Y2/NPY2R) is a presynaptically-expressed GPCR involved primarily with satiety signaling but also implicated broadly across neurological/endocrine functions due to its widespread distribution throughout brain regions like hippocampus/hypothalamus as well as peripheral tissues including gut epithelium. Its pharmacology includes both peptide agonists—especially truncated forms—and selective small-molecule antagonists useful for research into appetite control/anxiety/metabolic disease mechanisms.
GPCR signaling modulation; inhibition of neurotransmitter release; appetite regulation
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuropeptide Y receptor subtype 2 (Y2).